In Brief
Cellular reprogramming converts only a fraction of cells to the desired state. We analyze reprogramming of human fibroblasts to myotubes at pseudotemporal resolution using singlecell RNA-seq. We identified defects in BMP and insulin signaling as culprits using trajectory alignment, which enables quantitative comparison of gene expression kinetics across two biological processes.
INTRODUCTION
During development, cells undergo drastic shifts in gene expression and epigenetic configuration as they pass from progenitor or stem cell states to their differentiated states in the adult organism. Nevertheless, developmental decisions can be ''unmade'' by ectopic expression of a small number of regulatory genes, as first shown by Davis et al., who converted murine fibroblasts to myotube-like cells by overexpressing MyoD, a key myogenic transcription factor (Davis et al., 1987) . Numerous other reprogramming factors have since been discovered, most famously including four factors that reprogram many different cell types into induced pluripotent stem cells (iPSCs) (Takahashi and Yamanaka, 2006) . Following the discovery of MyoD-mediated transdifferentiation in fibroblasts, Weintraub et al. explored MyoD's ability to convert a diverse set of starting cell types to myotubes (Weintraub et al., 1989) . Interestingly, the ectopic expression of MyoD induced the expression of muscle-specific structural proteins without altering cell-specific functions. These studies, concomitant with contemporary heterokaryon experiments (Blau et al., 1983) , indicated that neither intracellular transcription factors nor ectopically transduced MyoD were sufficient for complete reprogramming to the myogenic cell fate. Despite the following decades of research on cellular conversions, including extensive studies of myogenic reprogramming, the molecular determinants that impede or mediate reprogramming remain poorly characterized.
Reprogramming can generate dramatically heterogeneous cell populations, with cells reaching drastically different molecular outcomes. Single-cell genomics assays provide a means of identifying the different outcomes and could reveal mechanisms that drive a cell to a particular one. For example, Truetlein et al. demonstrated through a single-cell transcriptome analysis that the overexpression of Ascl1, Brn2, and Myt1l generates both induced neurons and an alternative myocyte-like cell fate (Treutlein et al., 2016) . However, synthesizing measurements from these diverse outcomes into a useful picture of the molecular mechanisms that determine cell fate remains extremely challenging. Recently, we developed an algorithm that can automatically reconstruct the sequence of expression changes executed by a cell undergoing differentiation or reprogramming from single-cell RNA sequencing (RNA-seq) data. Our algorithm, called Monocle, introduced the notion of ''pseudotime,'' which measures each cell's progress through a biological process without the need for a priori knowledge of genes that define progression (Trapnell et al., 2014) . Moreover, Monocle can pinpoint branches that lead a cell to alternative outcomes, which can reveal the genes that direct a cell to its ultimate fate. Monocle's unsupervised learning algorithm enables the discovery of key steps, roadblocks, and intermediate cellular states on the path to differentiation.
More recently, we released Monocle 2, which deploys a new algorithm framework called ''reversed graph embedding'' that dramatically improves the accuracy, scalability, and robustness of Monocle's trajectory inference (Qiu et al., 2017a (Qiu et al., , 2017b . In particular, Monocle 2 was far better at identifying branch points that correspond to fate decisions made during cell differentiation. Despite the improvements in Monocle 2, the toolkit is still largely focused on the analysis of a single biological process. However, many experiments call for the comparison of two developmental processes. For example, one may wish to compare the impact of a particular mutation on the development of a given cell type relative to wild-type cells. Comparing two pseudotime trajectories is not straightforward because there is no universal ''unit'' of pseudotime. A new algorithm is needed to match up the most similar segments of each trajectory so that any differences that remain between them can be identified.
Here, we develop a novel approach for aligning two pseudotime trajectories and use it to compare human fibroblasts undergoing MYOD-mediated myogenic reprogramming to normal muscle cell development. Through an unsupervised single-cell RNA-seq analysis, we reveal that the trajectory includes branch points corresponding to key ''checkpoints'' in the process. Cells that travel down the correct branch progress, while those that travel down the alternatives fail to convert to myotubes. We show that the myogenic conversion trajectory does contain a path that is similar to normal myoblast differentiation but that many cells diverge from this path toward unproductive reprogramming outcomes.
RESULTS

Pseudotemporal Analysis of MYOD Overexpression Reveals Multiple Reprogramming Outcomes
We sought to compare the reprogramming activation of the skeletal muscle genes in non-muscle cells to their developmentally regulated onset in normal myoblasts. Previously, we analyzed primary human skeletal muscle myoblast (HSMM) differentiation using single-cell RNA-seq by culturing HSMMs to optimal confluence and then withdrawing mitogens from the growth medium (GM) (Trapnell et al., 2014) . Within 24 hr of the switch, HSMMs had exited the cell cycle, aligned with one another, and by 72 hr in differentiation (DM) had formed myosin heavychain (MHC)-positive myotubes. Monocle showed that HSMM cells follow a largely linear trajectory, albeit with a single small branch corresponding to non-differentiating myoblasts (i.e., ''reserve cells'') (Qiu et al., 2017a (Qiu et al., , 2017b . As cells followed this trajectory, they downregulated markers of the active proliferation (e.g., CCNB2) and then activated transcriptional regulators of the skeletal muscle program (e.g., MYOG), followed by genes associated with contractile myotubes (MYH3, DMD, ENO3, and others). To compare myoblast differentiation to myogenic reprogramming, we needed to engineer a fibroblast cell line in which the myoblast expression program could be induced in a tightly controlled manner.
To analyze myogenic reprogramming at single-cell resolution, we first derived a doxycycline-inducible MYOD fibroblast line (hFib-MyoD), enabling us to synchronize the onset of MYOD expression. The hFib-MyoD line also harbors a constitutively expressed human telomerase gene to alleviate passage-dependent stress, which we previously showed drastically improves uniformity and synchrony of induced pluripotency across cells (Cacchiarelli et al., 2015) . 72 hr of MYOD transgene expression was sufficient to produce conversion of fibroblasts to MHC-positive cells. However, as reported by previous studies (Salvatori et al., 1995) , myogenic reprogramming of human fibroblasts is a very inefficient process. Only a small proportion of cells are successfully reprogrammed, and the result is small, mononucleated, myocyte-like cells ( Figures 1A and 1B ) rather than long, multinucleated myotubes as generated by HSMM. The number of reprogrammed cells did not increase with longer time courses (not shown).
To investigate the molecular basis driving HSMM and hFibMyoD through the process of myogenic identity, we sampled single cells every 24 hr post myogenic induction and performed deep, single-cell, full-length RNA-seq using the Fluidigm C1 platform. We recovered a total of 466 high-quality libraries from two independent reprogramming time series experiments. Although some markers of myotube formation, such as ENO3, were induced by MYOD, others including DMD and MYOG showed expression patterns inconsistent with HSMM ( Figure 1C ). Few hFib-MyoD cells expressed MYOG even at 72 hr, which is required for the upregulation of many genes needed for terminal differentiation and contraction, including DMD (Bentzinger et al., 2012) . CDK1 and other genes associated with active proliferation, which were rapidly downregulated in HSMM within 24 hr following the switch to the differentiation medium, were more gradually lost, with some cells still expressing them even at 72 hr. The delayed cell-cycle exit may explain why hFib-MyoD wells contained greater than 3-fold cells than HSMM wells despite being seeded at comparable initial density ( Figure 1B ). Comparing average expression levels in cells collected at each time point revealed that few of the 653 genes that were significantly differentially expressed as a function of time in myoblasts were regulated to the same extent in hFib-MyoD ( Figure 1D ).
Single-Cell Trajectory Branch Points Correspond to Reprogramming Barriers
We next sought to identify the subset of hFib-MyoD cells that reached a muscle-like expression program and define the stepwise changes in gene expression that lead to conversion failure. Since both differentiation and reprogramming are characterized by high levels of asynchrony, obscuring the sequence of expression changes in such processes, we applied a recently improved version of Monocle (Qiu et al., 2017a) to hFib-MyoD. Monocle 2 reconstructed a trajectory capturing the progression of single cells through myogenic reprogramming ( Figure 1E ), which contained three termini (denoted ''F 1 ,'' ''F 2 ,'' and ''F 3 '') corresponding to three distinct reprogramming outcomes. Cells from two independent biological replicates were found at each of the three outcomes (Figure S1 ). To reach these outcomes, cells passed through at least one of two branch points (denoted ''B 1 '' and ''B 2 ''). The trajectory's root was populated largely by cells collected at the beginning of the experiment, while the three termini of the tree were populated by cells collected following the switch to doxycycline-containing media.
We next assessed the expression of genes regulated in myoblast differentiation in cells at the three different outcomes of the hFib-MyoD trajectory. The cells at outcome F 1 showed expression of genes upregulated early in myoblast differentiation, such as ENO3, but maintained strong expression of genes needed for active proliferation such as CDK1. (Figure 2A) We next examined the pseudotemporal kinetics of CDK1, ENO3, and TNNT2 as cells traveled from the root through branch point B 1 and then either to outcome F 1 or toward a second branch point B 2 . While ENO3 and TNNT2 were upregulated to a similar extent on both paths, CDK1 levels dropped markedly in cells traveling to the branch B 2 but remained high in cells traveling to F 1 ( Figure 2B) . A global differential analysis comparing the two paths away from branch point B 1 revealed 173 genes with branch-dependent expression (false discovery rate [FDR] < 1%), most of which were associated with the cell cycle. ( Figure 2C ; Table S1 ). We examined our previously collected HSMM data and found that in contrast to hFib-MyoD, key genes that mark proliferating cells (CCNB2 and CDK1) are almost never co-expressed with early myogenic markers (e.g., ENO3 and TNNT2) in these cells ( Figure 3 ). Although hFib-MyoD cells at F 1 co-expressed numerous markers of both proliferation and the early myoblast differentiation program, they expressed few markers of mature, contractile myotubes. In normal differentiating myoblasts, proliferation genes are downregulated prior to the onset of skeletal muscle genes, indicating that F 1 may be an aberrant cellular state within the myogenic reprogramming process.
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We next analyzed the path that led away from branch point B 1 to a second branch point B 2 , which in turn gave rise to outcomes F 2 and F 3 ( Figure 4A ). The cells at F 2 expressed MYOG, lacked markers of active proliferation, and showed upregulation of numerous genes needed for muscle contraction (Figures 4B and S2) . Branch-dependent expression analysis at B 2 showed significant changes in 277 genes (FDR < 10%), including a coherent cluster that included TNNI1, TNNT3, MYL4, and other notable proteins involved in myotube contraction (Table S2) (Figure 4C ). In contrast, cells at F 3 lacked expression of MYOG, cellcycle genes, and most of those needed for muscle contraction. We therefore concluded that B 1 is a decision point corresponding to whether a cell will exit the cell cycle, while B 2 is a decision point governing whether, having exited the cell cycle, it will go on to activate the myogenic program. Based on our differential analysis, we termed the three hFib-MyoD reprogramming outcomes F 1 , F 2 , and F 3 as ''cell-cycle exit failure,'' ''partial reprogramming,'' and ''reprogramming failure,'' respectively.
Aligning Single-Cell Trajectories via Dynamic Time Warping
Having identified the core trajectory from the fibroblast state to a partially reprogrammed state, we next sought to quantify the differences between this program of gene expression changes and the one associated with normal myoblast differentiation. In principle, combining the HSMM and hFib-MyoD cells and building a joint trajectory could show how the two cell types converge toward a muscle expression program, with cells of both types co-occupying positions of the graph corresponding to successful activation of the myogenic program. However, Monocle reconstructed a fully linear trajectory with no intermixing of cells at similar stages ( Figure S3A ). This is likely because despite having some genes regulated in a common direction such as MEF2C and ENO3, many other genes differ between the cell types, and these differences persist throughout reprogramming and differentiation.
We therefore developed a new algorithmic approach for comparing the HSMM and hFib-MyoD trajectories. A successful comparison between two trajectories should reveal to the user which cells from each are in similar gene expression states and which cells are in states unique to each biological process under study. Because the two single-cell trajectories were learned from each dataset independently, their pseudotime scales are not directly comparable; there is no universal ''unit'' of pseudotime. Simply combining two different cell types into a single Monocle analysis does not reveal any similarities between their trajectories. We thus devised a ''manifold alignment'' algorithm (Ham et al., 2003) based on dynamic time warping (DTW) (Vintsyuk, 1972) , which matches highly similar points on the two trajectories and creates a mapping between the HSMM and hFibMyoD pseudotime scales. (Figure 5 ; Data S1). DTW operates analogously to sequence alignment in that it reports how one trajectory must be deformed (i.e., dilated in some regions and contracted in others) in order to closely match the other trajectory. It matches up the most similar regions of the trajectories so their differences are apparent. In a complementary study published while this manuscript was in revision, Welch et al. devised an algorithm, MATCHER, that can align two linear pseudotemporal trajectories that have been reconstructed from different measurement types (e.g., gene expression and DNA methylation) (Welch et al., 2017) . Like MATCHER, our algorithm assumes the cells proceed through linear biological process monotonically and that progression through each biological process leads to measurable changes in gene expression. However, where MATCHER assumes that both experiments examine the same cell type, we aim to align cells of different types (e.g., fibroblasts and myoblasts) that proceed through similar processes.
Our algorithm aligned the HSMM and hFib-MyoD trajectories along a ''warping path'': a sequence of matchings between an HSMM and an hFib-MyoD cell such that the most transcriptomically similar cells (and thus points in HSMM and hFib-MyoD pseudotimes) are linked ( Figure 6A ). Just as ''edit distance'' in DNA sequence alignment measures the number of base transversions, insertions, and deletions needed to transform a sequence into one aligned to it, the length of this warping path quantifies the total amount of transcriptome ''distortion'' needed to transform one gene expression trajectory into another. Randomly permuting the order of the HSMM and hFib-MyoD cells and then aligning these shuffled trajectories produced far longer warping paths than the correctly ordered trajectories (Figure 6B) . Because warping path lengths of shuffled trajectories appeared to be normally distributed (p = 0.68, Shapiro-Wilk test), we were able to determine that the warping path between the unshuffled trajectories was significantly shorter (p < 10 À16 , t test), suggesting that DTW fixed on genuine biological signal to match up the pseudotime scales. Because our method assumes the two input trajectories are correctly inferred, we set out to explore the robustness of trajectory inference with Monocle 2 and its impact on downstream trajectory alignment. Monocle 2 produces trajectories that are robust to many choices of its parameter values, but there are several that can dramatically impact the topology of the trajectory. The set of genes used for ordering, which defines the high-dimensional space in which the original data reside prior to embedding, can have a major impact on the interpretation of the biological process under scrutiny (Qiu et al., 2017a (Qiu et al., , 2017b . When we used all 441 genes that varied significantly over time in the HSMM experiment instead of just the top 100, Monocle 2 produced a nearly identical HSMM trajectory, but the hFib-MyoD trajectory failed to capture the split between partially reprogrammed and unreprogrammed cells ( Figure S3B ). Changing one of Monocle 2's key regularization parameters had a similar effect. Ordering both sets of cells by genes that undergo time-dependent changes in expression in hFib-MyoD rather than HSMM led to a loss in the ''failure to exit'' branch in the hFibMyoD trajectory and a failure to place some MYOG+ cells on the partially reprogrammed branch ( Figure S3C ).
The alternative trajectories produced by changing the ordering genes or regularization parameters have some topological features in common with the one shown in Figure 2A , but each failed to segregate the cells of the ''reprogramming failure'' and ''partial reprogramming'' outcomes onto distinct paths. Because there is typically no experimentally derived ''ground truth'' ordering for a set of cells, benchmarking a trajectory's accuracy typically requires checking whether it can be reconciled with time series immunofluorescence or other kinetic measurements of the system. At the 72-hr post-serum switch, both cultures contain nuclei in MYH+ cells as well as cells lacking MYH (Figure 1) . Therefore, both trajectories should have at least two outcomes, one with partially reprogrammed cells (MYH+) and one in which the myogenic program failed to activate (MYHÀ). These analyses suggest that although Monocle 2 is somewhat sensitive to parameters, the trajectories we have aligned here are consistent with the independent techniques for assessing myogenic differentiation kinetics.
Aligning Single-Cell Trajectories Identifies Key Molecular Determinants of Myogenic Reprogramming
Because numerous pathways and transcriptional circuits play a role in muscle development, we therefore sought to use our alignment to reveal which of them might contribute to the failure of hFib-MyoD cells to fully reprogram. The alignment between HSMM and hFib-MyoD revealed extensive quantitative differences in expression kinetics between their trajectories, highlighting several coherent clusters of genes missing in hFibMyoD or aberrantly regulated relative to HSMM ( Figure 6C) . Most of the cell-cycle markers, such as CDK1, displayed similar kinetics in both hFib-MyoD and HSMM, indicating that on the core hFib-MyoD trajectory, the cell-cycle exit proceeds swiftly following media switch. MEF2C, a crucial co-factor for MYOD and MYOG in myoblasts, was upregulated with similar timing but to a lesser extent in hFib-MyoD. MYOG, in contrast, was upregulated far later in hFib-MyoD than HSMM, to a lesser extent, and in a smaller proportion of cells ( Figure 6D ).
In myoblasts, MEF2C and MYOG both auto-regulate their own expression (Edmondson et al., 1992; Wang et al., 2001) , after initially being upregulated by MYOD. MYOD activates its targets by forming a heterodimer with E47, which together recruit p300 to robustly transactivate the late myogenic expression program. The activity of p300 at MYOD-bound promoters is driven through Akt-mediated insulin signaling (Serra et al., 2007) . Formation of the MYOD/E47 heterodimer is inhibited by ID family proteins (Neuhold and Wold, 1993) , which sequester E proteins away from chromatin. In proliferating myoblasts, ID family proteins are maintained at high levels by an incompletely understood mechanism that is likely downstream of BMP signaling (Lewis and Prywes, 2013) , which acts to allow sufficient myoblast expansion from satellite cells during regeneration (Sartori et al., 2013) . During differentiation, ID expression drops, enabling E47 to form heterodimers with MYOD at promoters of key muscle genes. Expression levels of insulin receptor (INSR) and the insulin-like growth factor receptors (IGF1R and IGF2R) were significantly lower in hFib-MyoD. (Figure 6D ) IGF2, which drives myoblast differentiation in an autocrine loop (Florini et al., 1991) , was strongly upregulated in HSMMs but not hFibMyoD. Furthermore, ID1 and ID3 were at far higher levels in hFib-MyoD and were maintained throughout differentiation. BMP4 was expressed in hFib-MyoD, while HSMMs did not express BMP family mRNAs at appreciable levels. (Figure 6D ) We thus hypothesized that high levels of BMP and insufficient insulin signaling were locking hFib-MyoD cells in a negative feedback loop, preventing their efficient activation of the myotube expression program.
Cell-Extrinsic Factors Are Required for MYOD-Mediated Myogenic Reprogramming
To test whether modulating insulin or BMP signaling could enhance myogenic conversion efficiency, we supplemented the differentiation medium with recombinant insulin protein, a chemical inhibitor of the BMP receptor, or both. After 120 hr of conversion in the presence of insulin, hFib-MyoD showed marked increases in the number of myotubes ( Figure 7A ). Myoblasts cultured with insulin did not form significantly more myotubes, but myotube size, the number of nuclei residing in myotubes, and nuclei per myotube all increased at least 2-fold, indicating far more efficient fusion. Inhibition of BMP signaling also significantly increased the number, size, and nuclei count of hFib-MyoD-derived myotubes. (Figure 7B ) The addition of both insulin and the BMP inhibitor increased myotube number, size, and nucleation more than adding either alone, suggesting that these pathways act independently to modulate hFib-MyoD conversion efficiency. Importantly, neither insulin nor the BMP inhibitor altered the total number of nuclei in the experiment, indicating that variation in myotube efficiency was not due to variation in cell counts. Together, these results suggest that MYOD is sufficient to convert human foreskin fibroblasts to myotubes only in the presence of appropriate upstream signaling from core myogenic pathways.
MYOD has been characterized as a ''pioneer'' transcription factor because of its sufficiency in remodeling chromatin at inactive regulatory sites in the genome (Zaret and Carroll, 2011) . Recently, a number of studies have shown that genetically or chemically modulating the activity of chromatin remodeling enzymes alters the efficiency, timing, and heterogeneity of reprogramming to the pluripotent state. For example, we showed that inhibiting the activity of the histone demethylase LSD1, which removes mono-and di-methyl groups from lysine 4 in the tail of histone H3 (H3K4m1/2), improves fibroblast-to-iPSC conversion efficiency by 10-fold (Cacchiarelli et al., 2015) . Similarly, incubating hFib-MyoD cells with an LSD1 inhibitor dramatically increased their conversion to myotubes in the presence of insulin ( Figure 6D ). In contrast, the inhibitor had only a modest effect in the absence of insulin and no effect on HSMM differentiation.
DISCUSSION
The landmark discovery by Takahashi and Yamanaka that developmental decisions can be reversed with the ectopic expression of four factors, ultimately converting fibroblasts into pluripotent cells, raised the prospect of large-scale manufacture of arbitrary cell types and tissues. (Takahashi and Yamanaka, 2006) . During reprogramming, several key developmental decisions are observed (Cacchiarelli et al., 2015; Takahashi et al., 2014) . However, for most cell types, we lack effective protocols for differentiating them from pluripotent cells or direct ''reprogramming cocktails'' that would generate them from another cell type. The cocktails that do exist generally only work on one or a handful of initial cell types, often with poor and variable efficiency (Vierbuchen and Wernig, 2011) (Xu et al., 2015) . Developing better methods for dissecting the molecular basis for different reprogramming cocktails is therefore critical for realizing the promise of efficient manufacture of therapeutically relevant cells.
MYOD is perhaps the best characterized ectopic reprogramming factor and has been extensively studied as a model ''master regulator'' of cell fate. Central to its identity is its ability to single-handedly convert various cell types into muscle. However, as noted, some cell types, such as HeLa cells (Weintraub et al., 1989) , remain refractory to myogenic conversion for reasons that until recently remained poorly understood. Work by Forcales et al. showed that HeLa cells can be converted to myotubes with MYOD only when BAF60C, a subunit of the BAF ATP-dependent chromatin remodeling complex (present in mesodermal lineages), is also expressed along with appropriate signaling from p38ɑ (Forcales et al., 2012) . That is, MYOD's ability to reprogram to muscle is dependent upon the presence of factors needed for ATP-dependent chromatin remodeling.
Our study shows that the extracellular signaling environment must also be supportive for efficient MYOD-mediated reprogramming of fibroblasts to myotubes. Using pseudotemporal single-cell transcriptome analysis to ''debug'' our reprogramming system, we identified two molecular barriers to conversion. The first is the failure to engage a central autocrine positive feedback loop driven by insulin signaling, which is supplied by IGF2 in myoblasts. The second is that hFib-MyoD cells secrete BMP4, which may activate a negative autocrine loop and impede myogenic conversion. Supplementing the cellular milieu with insulin and a BMP inhibitor rescued MYOD's ability to convert these fibroblasts to myotubes. Although these pathways are known to play a role in muscle development and reprogramming, so do many others (Knight and Kothary, 2011) ; trajectory alignment identified these as the specific barriers in our system that should be disrupted to ease conversion. Alignment of singlecell trajectories is thus a powerful technique for isolating the sequence of productive state transitions leading to effective cell type conversion.
Dependence on a supportive extracellular signaling environment might explain variable reprogramming efficiency during not only myogenic reprogramming but many other reprogramming settings. Furthermore, while the importance of engaging regulatory feedback loops for reprogramming, differentiation, and maintenance of the pluripotent and other cellular states is The core trajectories of hFib-MyoD (left) and HSMM (center) were aligned using dynamic time warping (Giorgino, 2009; Rabiner and Juang, 1993; Vintsyuk, 1972) (DTW; right), a dynamic-programming time series alignment technique, which matches pseudotime coordinates on the hFib-MyoD trajectory to the most best matching points in the HSMM trajectory as determined by similarity in global expression.
well appreciated, feedback loops are most frequently discussed in the context of transcriptional circuits that govern these processes. Our work underscores the importance of establishing (or interrupting) autocrine signaling feedback loops in order to reach a desired cellular state.
Beyond providing insights into barriers to myogenic reprogramming, our study shows that pseudotemporal single-cell trajectory alignment is a powerful approach for dissecting biological processes. Alignment can reveal kinetic differences in how each gene is regulated in the two processes and could be useful for understanding not only how reprogramming compares to normal cell differentiation but also how a dynamic process proceeds differently under different environmental conditions or how a mutation alters it. Our alignment algorithm as well as other recently proposed approaches such as MATCHER make several assumptions regarding the underlying biological processes being compared. If these assumptions are not met, or if the trajectories provided as input are incorrectly constructed, the alignment will not yield an accurate picture of how the biological process under study is similar or different. It is conceivable that a future algorithm that jointly learns trajectories for two or more processes simultaneously along with the mapping Figure 6 . Alignment of Myogenic Reprogramming and Myoblast Differentiation Trajectories Identifies Insulin and BMP Signaling as Aberrantly Regulated in hFib-MyoD (A) The DTW alignment (cyan curve) follows a dissimilarity-minimizing path through the ''landscape'' of possible ways to pair up points on the two pseudotime curves. The contours indicate levels of equal similarity between global expression profiles of typical cells at indicated HSMM and hFib-MyoD pseudotimes. HSMM and hFib-MyoD cells were aligned to minimize differences in the union of genes used to order the two sets of cells. (B) The distribution of normalized lengths of the warping path as reported by the DTW package for shuffled trajectories. Shuffling was conducted immediately prior to computing all pairwise distances between points on the two pseudotime series. The red line indicates the length of the warping path (0.58) of the unshuffled data. (C) Clustered heatmap of genes showing significant differences in aligned kinetic curves (FDR < 10%; likelihood ratio test; see STAR Methods) after controlling for common pseudotime-dependent differences. Each row shows a different gene. Columns correspond to the log-transformed fold change of the curve for hFib-MyoD over that of HSMM at each point in the aligned trajectory. These values were further transformed into per-gene Z scores prior to clustering. Genes are clustered by Ward's method and tested for enrichment of genes in REACTOME pathways, with selected significantly enriched pathways shown. (D) Aligned kinetic curves for the indicated marker genes, all of which show significant differential pseudotime-dependent expression.
between them might be more robust to user-provided parameters. Despite these limitations, trajectory alignment can advance our understanding of not only how two biological processes relate to one another but also how different layers of gene regulation are linked in the same process. Trajectory alignment is applicable to these and many other settings and should yield Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contacts, Cole Trapnell (coletrap@uw.edu) and Davide Cacchiarelli (d.cacchiarelli@tigem.it) .
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Culture and Derivation HSMM derivation, expansion and differentiation was as previously described (Trapnell et al., 2014) . Foreskin Human Fibroblasts obtained from commercial vendor (Stemgent) were expanded in alpha-mem supplemented with glutamax, 10% FBS and 16ng/ul of FGF-b (ThermoFisher Scientific). The fibroblasts were then infected with a mixture of lentiviruses encoding hTERT (and Puromycin resistance gene) (pLVX system from Clontech), Tetracycline Repressor (and Geneticin resistance gene) and TR-controlled hMyoD (and Blasticidin resistance gene) (ViraPower T-Rex system from ThermoFisher Scientific). All the resistance genes are constitutively expressed and therefore triple selection was performed and maintained using 1ug/ml of Puromycin, 500ug/ml of Geneticin and 2ug/ml of Blasticidin to generate the hFib-MyoD line.
To perform reprogramming and differentiation experiments HSMM and hFib-MyoD cells were plated in 24-well formats at a density between 50.000 and 100.000 cells per well. Gelatin was sometime used as a coating agent with no significant difference with respect to uncoated dishes. Differentiation and reprogramming was induced using a differentiation media containing alpha-mem supplemented with glutamax and 2% HS (ThermoFisher Scientific), supplemented with 2ug/ml of doxycycline to enact MYOD expression. REAGENT 
